XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2021   55,756,233        
Beginning balance at Dec. 31, 2021 $ 2,209,853 $ 296,483 $ (118,027) $ 1,300,192 $ 741,648 $ (10,443)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 33,547       33,547  
Other comprehensive income (loss) (94,126)         (94,126)
Comprehensive income (loss) (60,579)          
Cash dividends (12,505)       (12,505)  
Issuance of common stock for stock-based compensation awards (in shares)   124,433        
Issuance of common stock for stock-based compensation awards (2,465)   3,977 (6,442)    
Stock-based compensation expense 3,338     3,338    
Ending balance (in shares) at Mar. 31, 2022   55,880,666        
Ending balance at Mar. 31, 2022 2,137,642 $ 296,483 (114,050) 1,297,088 762,690 (104,569)
Beginning balance (in shares) at Dec. 31, 2021   55,756,233        
Beginning balance at Dec. 31, 2021 2,209,853 $ 296,483 (118,027) 1,300,192 741,648 (10,443)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 119,792          
Other comprehensive income (loss) (205,609)          
Comprehensive income (loss) (85,817)          
Ending balance (in shares) at Sep. 30, 2022   55,953,104        
Ending balance at Sep. 30, 2022 2,092,281 $ 296,483 (111,577) 1,299,476 823,951 (216,052)
Beginning balance (in shares) at Mar. 31, 2022   55,880,666        
Beginning balance at Mar. 31, 2022 2,137,642 $ 296,483 (114,050) 1,297,088 762,690 (104,569)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 39,678       39,678  
Other comprehensive income (loss) (50,829)         (50,829)
Comprehensive income (loss) (11,151)          
Cash dividends (12,488)       (12,488)  
Issuance of common stock for stock-based compensation awards (in shares)   51,351        
Issuance of common stock for stock-based compensation awards (78)   1,755 (1,833)    
Stock-based compensation expense 2,952     2,952    
Ending balance (in shares) at Jun. 30, 2022   55,932,017        
Ending balance at Jun. 30, 2022 2,116,877 $ 296,483 (112,295) 1,298,207 789,880 (155,398)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 46,567       46,567  
Other comprehensive income (loss) (60,654)         (60,654)
Comprehensive income (loss) (14,087)          
Cash dividends (12,496)       (12,496)  
Issuance of common stock for stock-based compensation awards (in shares)   21,087        
Issuance of common stock for stock-based compensation awards (282)   718 (1,000)    
Stock-based compensation expense 2,269     2,269    
Ending balance (in shares) at Sep. 30, 2022   55,953,104        
Ending balance at Sep. 30, 2022 $ 2,092,281 $ 296,483 (111,577) 1,299,476 823,951 (216,052)
Beginning balance (in shares) at Dec. 31, 2022 55,953,104 55,953,104        
Beginning balance at Dec. 31, 2022 $ 2,136,016 $ 296,483 (111,577) 1,302,422 857,725 (209,037)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 46,078       46,078  
Other comprehensive income (loss) 16,713         16,713
Comprehensive income (loss) 62,791          
Cash dividends (12,561)       (12,561)  
Issuance of common stock for stock-based compensation awards (in shares)   120,554        
Issuance of common stock for stock-based compensation awards (2,391)   4,018 (6,409)    
Stock-based compensation expense 3,445     3,445    
Ending balance (in shares) at Mar. 31, 2023   56,073,658        
Ending balance at Mar. 31, 2023 $ 2,187,300 $ 296,483 (107,559) 1,299,458 891,242 (192,324)
Beginning balance (in shares) at Dec. 31, 2022 55,953,104 55,953,104        
Beginning balance at Dec. 31, 2022 $ 2,136,016 $ 296,483 (111,577) 1,302,422 857,725 (209,037)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 116,554          
Other comprehensive income (loss) 9,713          
Comprehensive income (loss) $ 126,267          
Ending balance (in shares) at Sep. 30, 2023 56,140,713 56,140,713        
Ending balance at Sep. 30, 2023 $ 2,233,323 $ 296,483 (105,300) 1,304,891 936,573 (199,324)
Beginning balance (in shares) at Mar. 31, 2023   56,073,658        
Beginning balance at Mar. 31, 2023 2,187,300 $ 296,483 (107,559) 1,299,458 891,242 (192,324)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 28,643       28,643  
Other comprehensive income (loss) 863         863
Comprehensive income (loss) 29,506          
Cash dividends (12,573)       (12,573)  
Issuance of common stock for stock-based compensation awards (in shares)   58,820        
Issuance of common stock for stock-based compensation awards 1,000   1,970 (970)    
Stock-based compensation expense 3,395     3,395    
Ending balance (in shares) at Jun. 30, 2023   56,132,478        
Ending balance at Jun. 30, 2023 2,208,628 $ 296,483 (105,589) 1,301,883 907,312 (191,461)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 41,833       41,833  
Other comprehensive income (loss) (7,863)         (7,863)
Comprehensive income (loss) 33,970          
Cash dividends (12,572)       (12,572)  
Issuance of common stock for stock-based compensation awards (in shares)   8,235        
Issuance of common stock for stock-based compensation awards (127)   289 (416)    
Stock-based compensation expense $ 3,424     3,424    
Ending balance (in shares) at Sep. 30, 2023 56,140,713 56,140,713        
Ending balance at Sep. 30, 2023 $ 2,233,323 $ 296,483 $ (105,300) $ 1,304,891 $ 936,573 $ (199,324)